elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47552162-42798B29-89C7-4F3F-81A3-CB04BCB6B8CA
Q47552162-42798B29-89C7-4F3F-81A3-CB04BCB6B8CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47552162-42798B29-89C7-4F3F-81A3-CB04BCB6B8CA
Update on radionuclide therapy in oncology.
P2860
Q47552162-42798B29-89C7-4F3F-81A3-CB04BCB6B8CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47552162-42798B29-89C7-4F3F-81A3-CB04BCB6B8CA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
31215c7493b3e166b41c1c0980d6b5e02167bfc9
P2860
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.